• Please log in or register to access this feature.

Original Article

You have full text access to this OnlineOpen article

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1

  1. Zongtang Sun M.D.1,*,
  2. Peixin Lu2,
  3. Mitchell H. Gail3,
  4. David Pee4,
  5. Qinan Zhang2,
  6. Lihua Ming1,
  7. Jinbing Wang2,
  8. Yan Wu2,
  9. Guoting Liu1,
  10. Yuying Wu1,
  11. Yuanrong Zhu2

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510300204

Issue

Hepatology

Hepatology

Volume 30, Issue 2, pages 379–383, August 1999

Additional Information

How to Cite

Sun, Z., Lu, P., Gail, M. H., Pee, D., Zhang, Q., Ming, L., Wang, J., Wu, Y., Liu, G., Wu, Y. and Zhu, Y. (1999), Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology, 30: 379–383. doi: 10.1002/hep.510300204

Author Information

  1. 1

    Cancer Institute, National Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences, Beijing, China

  2. 2

    Liver Cancer Institute, Jiangsu, China

  3. 3

    National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda MD

  4. 4

    Information Management Services, Rockville, MD

*Cancer Institute, Chinese Academy of Medical Sciences, Panjiayuan, Beijing 100021, China. fax: 8610-6771-3917

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 20 APR 1999
  4. Manuscript Received: 16 FEB 1999

Funded by

  • Chinese Academy of Medical Sciences and Cancer Research Institute (Roger E. Green Memorial Fund)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (54K)

References

  • 1
    Li LD, Lu FZ, Zhang SW, Mu R, Sun ST, Huangpu XM, Sun J, et al. Cancer Mortality Survey, 1990-1992. [in Chinese] Journal of Chinese Oncology 1996; 18:403–407.
  • 2
    Ross RK, Yuan J-M, Yu MC, Wogan GN, Qian G-S, Tu J-T, Groopman JD, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339:943–946. MEDLINE
  • 3
    Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson BE, Wogan GN, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3:3–10. MEDLINE
  • 4
    Sun T, Chu Y. Carcinogenesis and prevention strategy of liver cancer in area of prevalence. In MakTW, TannockI, eds. Cellular and Molecular Biology of Neoplasia. New York: Alan R. Liss. 1984; 39–44.
  • 5
    Wu S, Wei Y, Ku G, Liu K, Sun ZT. Study on urinary excretion of AFM1 in Beijing and Qidong people. [in Chinese] Chin J Oncol 1984; 6:163–167.
  • 6
    Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427–428. MEDLINE
  • 7
    Ozturk M, et al. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338:1356–1359. MEDLINE
  • 8
    Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B 1972; 34:187–220.
  • 9
    Tsai W-Y, Jewell NP, Wang M-C. A note on the product-limit estimator under right censoring and left truncation. Biometrika 1987; 74:883–886.
  • 10
    Wogan GN. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res 1992; 52(Suppl):2114S–2118S. MEDLINE
  • 11
    Sun T, Wu S, Wu Y, Chu Y. Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma. In: HayashiY, NagaoM, SugimuraT, TakayamaS, TomatisL, WattenbergLW, WoganGN, eds. Diet, Nutrition and Cancer. Tokyo: Japan Sci Soc Press, 1986; 225–235.
  • 12
    Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855–4878. MEDLINE
  • 13
    Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tusbota A, Koida I, Arase Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective obervation of 2215 patients. J Hepatol 1998; 28:930–938. MEDLINE
  • 14
    Sun C-A, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 1996; 5:173–178. MEDLINE
  • 15
    London WT, Evans AA, McGlynn K, Buetow K, An P, Gao LL, Lustbader E, et al. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 1995; 38:155–161. MEDLINE
Get PDF (54K)